PDL BioPharma: PDL BioPharma to Host Fourth-Quarter and Full-Year 2008 Financial Results Conference Call on March 2, 2009

Health and Fitness Health and Fitness

Mon, March 2, 2009

[ Mon, Mar 02nd 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Submits .. for XIAFLEX(TM) for the Treatment of Dupuytren's

[ Mon, Mar 02nd 2009 ] - Market Wire

Constellation Software Inc.: Midwest Energy Inc. .. ary of Constellation Software's Harris Subsidiary

[ Mon, Mar 02nd 2009 ] - Market Wire

Sun Healthcare Group, Inc.: Sun Healthcare Group, .. Earnings; Strong Results Led by Growth in Skilled

[ Mon, Mar 02nd 2009 ] - Market Wire

Wellstar International, Inc.: Wellstar/TMI to Uti .. Board Members in the Marketing of Imaging Systems

[ Mon, Mar 02nd 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma Announces Fourth Quarter and Full Year 2008 Financial Results

[ Mon, Mar 02nd 2009 ] - Market Wire

NeuroInvestment: Migraine Therapeutics Reviewed by NeuroInvestment

[ Mon, Mar 02nd 2009 ] - Market Wire

Hansen Medical, Inc.: Hansen Medical Announces St .. anced Cardiac Therapeutics and Procurement of Cer

[ Mon, Mar 02nd 2009 ] - Market Wire

Watson Pharmaceuticals: Watson to Present at Barclays Capital Global Healthcare Conference

[ Mon, Mar 02nd 2009 ] - Market Wire

Pentaho Corporation: Cardiac Science Selects Pentaho to Streamline Information Integration

[ Mon, Mar 02nd 2009 ] - Market Wire

Targeted Genetics: Targeted Genetics Provides Business Update and Announces Extended Cash Horizon

Fri, February 27, 2009

[ Fri, Feb 27th 2009 ] - Market Wire

Proton Laboratories Inc.: Proton Laboratories Signs $18,500,000 Advertising Deal

[ Fri, Feb 27th 2009 ] - Market Wire

Rexahn Pharmaceuticals Receives Notice from NYSE Alternext US LLC

[ Fri, Feb 27th 2009 ] - Market Wire

Nanobac Pharmaceuticals: Nanobac Message to Shareholders

[ Fri, Feb 27th 2009 ] - Market Wire

Schaeffer's Street Stories: AstraZeneca plc Plunges on FDA Concerns Regarding Seroquel Approval

[ Fri, Feb 27th 2009 ] - Market Wire

UnitedHealth Group to Open New Service Center in Harlingen, Texas

[ Fri, Feb 27th 2009 ] - Market Wire

Healthways Participates in New NCQA Wellness & Health Promotion Accreditation Program

[ Fri, Feb 27th 2009 ] - Market Wire

Cougar Biotechnology Announces Presentation of Po .. etate) Phase II Data at ASCO 2009 Genitourinary C

[ Fri, Feb 27th 2009 ] - Market Wire

Health Net Federal Services Wins Department of Ve .. d Outpatient Clinic Contract in Durango, Colorado

[ Fri, Feb 27th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation Sets Annual Meeting Date

[ Fri, Feb 27th 2009 ] - Market Wire

AMAG Pharmaceuticals, Inc. Reports Financial Resu .. for the Quarter and Year Ended December 31, 2008

[ Fri, Feb 27th 2009 ] - Market Wire

Emergent BioSolutions to Webcast Presentation at .. Health Care Conference on Tuesday, March 17, 2009

[ Fri, Feb 27th 2009 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Launches New Wa .. se(R) MD Turbo(TM) All-Tissue Dental Laser System

[ Fri, Feb 27th 2009 ] - Market Wire

Celldex Reports Fourth Quarter and Fiscal 2008 Financial Results

[ Fri, Feb 27th 2009 ] - Market Wire

EPIX Pharmaceuticals Announces Resignation of Chief Business Officer

[ Fri, Feb 27th 2009 ] - Market Wire

Panacos Announces Voluntary Decision to Delist Co .. aq and Terminate SEC Registration of Common Stock

[ Fri, Feb 27th 2009 ] - Market Wire

Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day

Thu, February 26, 2009

[ Thu, Feb 26th 2009 ] - Market Wire

Dynavax to Report Fourth Quarter and Year End 2008 Financial Results on March 2, 2009

[ Thu, Feb 26th 2009 ] - Market Wire

Somaxon Receives Complete Response Letter from the FDA for Silenor® (doxepin)

[ Thu, Feb 26th 2009 ] - Market Wire

Cyclogenix Enters Research Collaboration with Wyeth Pharmaceuticals and Queensland?s IMBcom

[ Thu, Feb 26th 2009 ] - Market Wire

European Authorities Approve Larger-Scale Production of Genzyme?s Myozyme

[ Thu, Feb 26th 2009 ] - Market Wire

The Medicines Company: The Medicines Company Comp .. Acquisition of Targanta Therapeutics Corporation

[ Thu, Feb 26th 2009 ] - Market Wire

A Senior Cancer Researcher Joins PhytoMedical on .. uccessful Preclinical Study on Human Brain Cancer

[ Thu, Feb 26th 2009 ] - Market Wire

ArQule to Report Fiscal 2008 Financial Results on March 5, 2009

[ Thu, Feb 26th 2009 ] - Market Wire

Clinical Data, Inc. Announces $50 Million Convertible Debt Financing

[ Thu, Feb 26th 2009 ] - Market Wire

Optimer Pharmaceuticals Announces Publication in .. rulifloxacin?s Antibacterial Activity against Inf

[ Thu, Feb 26th 2009 ] - Market Wire

70 Abstracts Evaluatingthe Potential of Celgene P .. Be Presented at the 12th International Myeloma W

[ Thu, Feb 26th 2009 ] - Market Wire

Invitrogen Earns AmeriStar Award for GIBCO Cell Culture Bottle Design

[ Thu, Feb 26th 2009 ] - Market Wire

Conceptus Appoints John L. Bishop to Board of Directors

[ Thu, Feb 26th 2009 ] - Market Wire

Natus Medical Announces Record 2008 Fourth Quarter and Full Year Results

[ Thu, Feb 26th 2009 ] - Market Wire

Regeneron Reports Full Year and Fourth Quarter 2008 Financial and Operating Results

[ Thu, Feb 26th 2009 ] - Market Wire

CPEX Pharmaceuticals Announces Completion of Phas .. rial for Urology Drug by Serenity Pharmaceuticals

[ Thu, Feb 26th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Pozen In .. Corp., Agrium, CF Industries and Terra Industries

Wed, February 25, 2009

[ Wed, Feb 25th 2009 ] - Market Wire

Adolor Corporation Reports Year-End 2008 Financial Results

[ Wed, Feb 25th 2009 ] - Market Wire

Quidel Reports Fourth Quarter and Full Year 2008 Results

[ Wed, Feb 25th 2009 ] - Market Wire

Biovail Receives Requisition from Dissident Shareholder Eugene Melnyk

[ Wed, Feb 25th 2009 ] - Market Wire

Data on PolyMedix Antimicrobial Compounds Present .. robiology 7th Annual Biodefense and Emerging Dise

[ Wed, Feb 25th 2009 ] - Market Wire

Anika Therapeutics Announces Date of Fourth Quart .. d Year End 2008 Financial Results Conference Call

[ Wed, Feb 25th 2009 ] - Market Wire

Advanced Medical Optics, Inc. Announces Expiratio .. and Consent Solicitation for Its 7% Senior Subor

[ Wed, Feb 25th 2009 ] - Market Wire

Operations Executive Joins ReGen Biologics

[ Wed, Feb 25th 2009 ] - Market Wire

Synovis Life Technologies Reports 19 Percent Reve .. irst Quarter; Diluted EPS Increases 55 Percent to

[ Wed, Feb 25th 2009 ] - Market Wire

Dyax Corp. Announces Fourth Quarter and Year End 2008 Financial Results

[ Wed, Feb 25th 2009 ] - Market Wire

Adipose-Derived Stem and Regenerative Cells Preve .. ity and Reduce Kidney Damage in Preclinical Study

[ Wed, Feb 25th 2009 ] - Market Wire

Ceragenix and Pediapharm Enter Into Distribution and Supply Agreement for EpiCeram®

[ Wed, Feb 25th 2009 ] - Market Wire

Alexion?s Soliris(R) (eculizumab) Receives Market .. g Approval in Australia for All Patients with PNH

[ Wed, Feb 25th 2009 ] - Market Wire

Zacks Bull and Bear of the Day Highlights: Onyx P .. Bristol Myers, Biogen Idec and Strayer Education

[ Wed, Feb 25th 2009 ] - Market Wire

A.P. Pharma Appoints John B. Whelan as Chief Financial Officer

[ Wed, Feb 25th 2009 ] - Market Wire

Zacks Industry Outlook Highlights: Immucor

[ Wed, Feb 25th 2009 ] - Market Wire

Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process

Tue, February 24, 2009

[ Tue, Feb 24th 2009 ] - Market Wire

Luminex Corporation Announces the Release of xPONENT® 3.1 Software

[ Tue, Feb 24th 2009 ] - Market Wire

Harvard Pilgrim Health Care Initiates Coverage for Microvolt T-Wave Alternans Testing

[ Tue, Feb 24th 2009 ] - Market Wire

HemaCare Corporation: HemaCare Reports Record 4th Quarter and 2008 Revenues

[ Tue, Feb 24th 2009 ] - Market Wire

Marshall Edwards, Inc.: Yale Researchers Present .. iol Clinical Trial in Prostate Cancer Patients at

[ Tue, Feb 24th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Exhibits at PDAC, Booth 2529

[ Tue, Feb 24th 2009 ] - Market Wire

Free Electronic Prescribing Service Now Available to San Antonio Physicians

[ Tue, Feb 24th 2009 ] - Market Wire

Health Net Announces New Enterprise-Wide Quality Office

[ Tue, Feb 24th 2009 ] - Market Wire

Assisted Living Concepts, Inc.: Assisted Living C .. Fourth Quarter and Full Year Results -- Solid Fou

[ Tue, Feb 24th 2009 ] - Market Wire

St. Jude Medical Receives Australian TGA Regulato .. for the World?s Smallest and Longest-Lasting Rec

[ Tue, Feb 24th 2009 ] - Market Wire

Optimer Pharmaceuticals Announces Positive Result .. f Prulifloxacin for Infectious Diarrhea in Travel

[ Tue, Feb 24th 2009 ] - Market Wire

Cypress Bioscience Inc.: Cypress Bioscience, Inc. .. ne Technology Platform From Cellatope Corporation

[ Tue, Feb 24th 2009 ] - Market Wire

CPEX Pharmaceuticals Initiates Phase II Clinical Trial of Nasulin®

[ Tue, Feb 24th 2009 ] - Market Wire

Salix Pharmaceuticals Announces 4Q2008 and FY2008 Financial Results Conference Call and Webcast

[ Tue, Feb 24th 2009 ] - Market Wire

Resumen: Biogen Idec nombra a Michael Lytton vicepresidente ejecutivo de desarrollo empresarial

[ Tue, Feb 24th 2009 ] - Market Wire

Bioject Enters into a Collaborative Research Agre .. IAVI for the Delivery of an HIV Vaccine Candidate

[ Tue, Feb 24th 2009 ] - Market Wire

Acorda Therapeutics Reports Fourth Quarter and Full Year 2008 Financial Results

Mon, February 23, 2009

[ Mon, Feb 23rd 2009 ] - Market Wire

Celldex to Report Fourth Quarter and Fiscal 2008 Financial Results on February 27, 2009

[ Mon, Feb 23rd 2009 ] - Market Wire

MDRNA, Inc.: MDRNA Successfully Silences Gene Tar .. ts in Animal Models Using Novel UsiRNA Constructs

[ Mon, Feb 23rd 2009 ] - Market Wire

Medtronic Acquires Ventor Technologies Ltd.

[ Mon, Feb 23rd 2009 ] - Market Wire

Harte Gold Corp.: Harte Announces Change of Auditor

[ Mon, Feb 23rd 2009 ] - Market Wire

Aradigm Announces $4.1 Million Registered Direct Offering

[ Mon, Feb 23rd 2009 ] - Market Wire

Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer

[ Mon, Feb 23rd 2009 ] - Market Wire

CytRx?s Arimoclomol to be Administered in a Phase .. l Trial in a Subset of Patients with Familial ALS

[ Mon, Feb 23rd 2009 ] - Market Wire

Editorial Article in the Clinical Chemistry Highl .. n Optimization of the Non-Invasive Transrenal DNA

[ Mon, Feb 23rd 2009 ] - Market Wire

Celsion to Report Clinical Trial Update of Thermo .. Breast Cancer Study at the Society for Thermal Me

[ Mon, Feb 23rd 2009 ] - Market Wire

Optimer Pharmaceuticals Appoints Industry Veteran .. s Chief Scientific Officer and Peter E. Grebow to

[ Mon, Feb 23rd 2009 ] - Market Wire

GTx Initiates Phase I Clinical Trial for GTx-758, .. ng Hormone Inhibitor for Advanced Prostate Cancer

[ Mon, Feb 23rd 2009 ] - Market Wire

Japanese Researchers Find CSA-13 May Be Useful fo .. reatment of Dental Caries and Periodontal Disease

[ Mon, Feb 23rd 2009 ] - Market Wire

Amedisys to Host Investor Day

[ Mon, Feb 23rd 2009 ] - Market Wire

CytoCore Signs Agreement to Sell Synermed?s General Cytology Preservative with SoftPAP

[ Mon, Feb 23rd 2009 ] - Market Wire

Cardima Completes Second Atrial Fibrillation Training Session in Thailand

Sun, February 22, 2009

[ Sun, Feb 22nd 2009 ] - Market Wire

Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal

Fri, February 20, 2009

[ Fri, Feb 20th 2009 ] - Market Wire

Midland Exploration Inc.: Midland Exploration Grants 420,000 Stock Options

[ Fri, Feb 20th 2009 ] - Market Wire

Harte Gold Corp.: Harte Gold Corp. Grant of Options and Issue of Shares for Debt

[ Fri, Feb 20th 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma to Host Fourth-Quart .. inancial Results Conference Call on March 2, 2009

[ Fri, Feb 20th 2009 ] - Market Wire

Chemed Corporation to Present at Baird?s 2009 Business Solutions Conference

[ Fri, Feb 20th 2009 ] - Market Wire

Study of Genzyme Oral Compound for Gaucher Disease Meets Primary Endpoint

[ Fri, Feb 20th 2009 ] - Market Wire

Humana Names Paul Kusserow Senior Vice President and Chief Strategy Officer

[ Fri, Feb 20th 2009 ] - Market Wire

Orthovita to Present at the Canaccord Adams Musculoskeletal Conference

[ Fri, Feb 20th 2009 ] - Market Wire

ARIAD Announces $24.3 Million Registered Direct Financing

[ Fri, Feb 20th 2009 ] - Market Wire

Ophthalmic Imaging Systems Comments on Potential .. timulus Package on Electronic Health Records Mark

[ Fri, Feb 20th 2009 ] - Market Wire

Targanta Enters into Memorandum of Understanding to Resolve Shareholder Lawsuit

[ Fri, Feb 20th 2009 ] - Market Wire

EnteroMedics Announces $15.89 Million Private Placement

[ Fri, Feb 20th 2009 ] - Market Wire

StemCells, Inc. Comments on PLoS Medicine Article Concerning Cell Transplants in Russia

[ Fri, Feb 20th 2009 ] - Market Wire

EPIX Pharmaceuticals to Present Preclinical Data for Two Programs at Keystone Symposia

[ Fri, Feb 20th 2009 ] - Market Wire

WellCare Responding to Concerns Raised by Centers for Medicare & Medicaid Services

[ Fri, Feb 20th 2009 ] - Market Wire

Strategic Re-alignment Continues - Fourth Quarter 2008 Financial Results Reported

Thu, February 19, 2009

[ Thu, Feb 19th 2009 ] - Market Wire

La Jolla Pharmaceutical Company Announces Reduction in Workforce and Evaluates Strategic Options

[ Thu, Feb 19th 2009 ] - Market Wire

Metropolitan Health Networks to Announce Fourth Quarter and Fiscal 2008 Results

[ Thu, Feb 19th 2009 ] - Market Wire

Genzyme Receives Positive Opinion on Myozyme from CHMP

[ Thu, Feb 19th 2009 ] - Market Wire

Wound Management Technologies, Inc.: OTC Financia .. te Profile on Wound Management Technologies, Inc.

[ Thu, Feb 19th 2009 ] - Market Wire

Medtronic Board Approves Fourth Quarter Cash Dividend

[ Thu, Feb 19th 2009 ] - Market Wire

BioMimetic Therapeutics, Inc. to Highlight Pre-Cl .. and Clinical Activities at ORS and AAOS Meetings

[ Thu, Feb 19th 2009 ] - Market Wire

San Anton Resource Corporation: San Anton Announces Cerro Del Gallo Project Update

[ Thu, Feb 19th 2009 ] - Market Wire

XELR8 Holdings, Inc.: XELR8 Holdings, Inc. Retain .. LC to Implement Global Investor Relations Program

[ Thu, Feb 19th 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Announces Trea .. temic Clinical Trial of AVI-4658 for Treatment of

[ Thu, Feb 19th 2009 ] - Market Wire

Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma

[ Thu, Feb 19th 2009 ] - Market Wire

MiddleBrook Pharmaceuticals Schedules Conference .. 08 Fourth Quarter and Full-Year Financial Results

[ Thu, Feb 19th 2009 ] - Market Wire

Enzon Reports 2008 Results

[ Thu, Feb 19th 2009 ] - Market Wire

Invacare Corporation Announces Appointment of Dale C. LaPorte to Board of Directors

[ Thu, Feb 19th 2009 ] - Market Wire

Forensic DNA Shown to Lower Crime Rates and Decrease Property Loss

[ Thu, Feb 19th 2009 ] - Market Wire

Antigenics Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights

Wed, February 18, 2009

[ Wed, Feb 18th 2009 ] - Market Wire

Resumen: Estudio revelador publicado en The Lance .. � de Celgene demuestra supervivencia sin preceden

[ Wed, Feb 18th 2009 ] - Market Wire

Remedent, Inc.: Remedent Sets Third Fiscal Quarte .. ce Call for Tuesday, February 24 at 11:00 a.m. ET

[ Wed, Feb 18th 2009 ] - Market Wire

PDL BioPharma: PDL BioPharma Receives Nasdaq Notice Related to Audit Committee Composition

[ Wed, Feb 18th 2009 ] - Market Wire

Orthofix International to Participate in Canaccord Adams Musculoskeletal Conference

[ Wed, Feb 18th 2009 ] - Market Wire

DelSite, Inc: DelSite Announces Intention to Lice .. nufacturing Rights, Fields of Use and Territories

[ Wed, Feb 18th 2009 ] - Market Wire

FONAR Corporation: FONAR Reports Profit and 2nd Quarter Fiscal 2009 Financial Results

[ Wed, Feb 18th 2009 ] - Market Wire

ReGen Biologics Initiates Training Program for U.S. Surgeons

[ Wed, Feb 18th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. h Quarter and Full Year 2008 Financial Results, a

[ Wed, Feb 18th 2009 ] - Market Wire

Allion Healthcare Announces Date of Fourth Quarter 2008 Financial Results and Conference Call

[ Wed, Feb 18th 2009 ] - Market Wire

Dyax Corp. to Host Fourth Quarter and Year End 2008 Earnings Call and Webcast

[ Wed, Feb 18th 2009 ] - Market Wire

IsoRay, Inc. Announces Distribution Agreement with BrachySciences

[ Wed, Feb 18th 2009 ] - Market Wire

GTx Announces Toremifene 80 mg NDA Accepted for Review by FDA

[ Wed, Feb 18th 2009 ] - Market Wire

Emeritus Announces Resignation of Chief Operating Officer

[ Wed, Feb 18th 2009 ] - Market Wire

Incyte Reports Fourth Quarter and Year-End 2008 F .. ancial Results; Announces 2009 Financial Guidance

[ Wed, Feb 18th 2009 ] - Market Wire

High-Throughput Genotyping of AML Patients for a .. eptor May Significantly Improve Treatment Outcome

Tue, February 17, 2009

[ Tue, Feb 17th 2009 ] - Market Wire

Teva Invites Public to Listen to Investor & Analyst Meeting Webcast

[ Tue, Feb 17th 2009 ] - Paula Catchpole

New Study From Plastic and Reconstructive Surgery Journal Shows How Not To Look Old.

[ Tue, Feb 17th 2009 ] - Market Wire

Remedent, Inc.: Remedent Engages Liolios Group to Lead New Investor Relations Program

[ Tue, Feb 17th 2009 ] - Market Wire

Depomed Initiates Phase I Trial for DM-1992 Progr .. lowing Positive Results of Preclinical Studies Sp

[ Tue, Feb 17th 2009 ] - Market Wire

AVANIR Announces Fiscal 2009 First Quarter Financial Results

[ Tue, Feb 17th 2009 ] - Market Wire

Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results

[ Tue, Feb 17th 2009 ] - Market Wire

Affymax Announces $42 Million Private Placement

[ Tue, Feb 17th 2009 ] - Market Wire

BioSante Pharmaceuticals, Inc. Presents LibiGel® .. nical and Market Information at ISSWSH Conference

[ Tue, Feb 17th 2009 ] - Market Wire

St. Jude Medical Welcomes Introduction of Legislation to Help People Suffering From Pain

[ Tue, Feb 17th 2009 ] - Market Wire

Sepracor Announces Tender Offer for 0% Convertible Senior Subordinated Notes Due 2024

[ Tue, Feb 17th 2009 ] - Market Wire

Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections

[ Tue, Feb 17th 2009 ] - Market Wire

Natus Medical to Hold 2008 Fourth Quarter Financial Results Conference Call on February 26

[ Tue, Feb 17th 2009 ] - Market Wire

California Hospital Implements ZOLL AutoPulse

[ Tue, Feb 17th 2009 ] - Market Wire

Acorda Therapeutics to Host Conference Call to Re .. Year 2008 Financial Results on February 24, 2009

[ Tue, Feb 17th 2009 ] - Market Wire

GTX Reports Fourth Quarter and Year End 2008 Results

[ Tue, Feb 17th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Baxter I .. nal, Marriott International, UDR, AIV and Vornado

Mon, February 16, 2009

[ Mon, Feb 16th 2009 ] - Market Wire

Constellation Software Inc.: Constellation Softwa .. Call to Discuss Fourth Quarter and Annual Results

[ Mon, Feb 16th 2009 ] - Market Wire

Wright Medical Group, Inc. to Participate in The Canaccord Adams Musculoskeletal Conference

[ Mon, Feb 16th 2009 ] - Market Wire

LifeVantage Corporation Announces the Addition of .. ing Network Marketing Distributors and Executives

[ Mon, Feb 16th 2009 ] - Market Wire

Applied Biosystems and Baylor College of Medicine .. ons to First Data Release of 1000 Genomes Project

Fri, February 13, 2009

[ Fri, Feb 13th 2009 ] - Market Wire

Signature Eyewear Reports Net Income for 2008

[ Fri, Feb 13th 2009 ] - Market Wire

Hypertension Diagnostics: Hypertension Diagnostics Announces FY 2009 Second Quarter Results

[ Fri, Feb 13th 2009 ] - Market Wire

Genta Incorporated Announces Fourth Quarter and Y .. d 2008 Financial Results and Corporate Highlights

[ Fri, Feb 13th 2009 ] - Market Wire

Orthovita to Present at the Roth Capital Partners 21st Annual Growth Stock Conference

[ Fri, Feb 13th 2009 ] - Market Wire

Enzon to Release Fourth Quarter 2008 Earnings on .. y 19, 2009; Conference Call and Webcast to Follow

[ Fri, Feb 13th 2009 ] - Market Wire

Universittsklinikum Heidelberg untersucht fortschrittliche Tomotherapie-Bestrahlungstechnik

[ Fri, Feb 13th 2009 ] - Market Wire

MDRNA, Inc.: MDRNA, Inc. Announces Licensing Agreement With Roche

[ Fri, Feb 13th 2009 ] - Market Wire

Bond Laboratories, Inc. Announces the Appointment .. keting Executives as President and Executive Vice

[ Fri, Feb 13th 2009 ] - Market Wire

Mannatech Presents Scientific Posters at Scripps .. icine?s 6th Annual Natural Supplements Conference

[ Fri, Feb 13th 2009 ] - Market Wire

Pioneer Behavioral Health: PHC Reports Second Quarter Fiscal 2009 Results

[ Fri, Feb 13th 2009 ] - Market Wire

Geron Corporation Announces Pricing of Common Stock Offering

[ Fri, Feb 13th 2009 ] - Market Wire

Adrenalina Discloses Its Four Nominees for Election to the Pacific Sunwear Board

[ Fri, Feb 13th 2009 ] - Market Wire

Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. l Partners 21st Annual OC Growth Stock Conference

[ Fri, Feb 13th 2009 ] - Market Wire

Electro-Optical Sciences, Inc.: Electro-Optical S .. op-Line Results From Landmark MelaFind(R) Pivotal

[ Fri, Feb 13th 2009 ] - Market Wire

Obagi Medical Products to Report Fourth Quarter a .. ial Results and Host a Conference Call on March 5

Thu, February 12, 2009

[ Thu, Feb 12th 2009 ] - Market Wire

Osiris Announces Fourth Quarter and Full Year 2008 Financial Results Conference Call

[ Thu, Feb 12th 2009 ] - Market Wire

Theravance, Inc.: Theravance Reports Fourth Quarter and Full Year 2008 Results

[ Thu, Feb 12th 2009 ] - Market Wire

Targacept Reports Fourth Quarter and 2008 Financial Results

[ Thu, Feb 12th 2009 ] - Market Wire

Biovail Announces Fourth-Quarter 2008 Earnings Release, Conference-Call Details

[ Thu, Feb 12th 2009 ] - Market Wire

I-Flow Will Present at the Roth Capital Partners .. nce Wednesday, February 18, 2009 at 4:00 p.m. PST

[ Thu, Feb 12th 2009 ] - Market Wire

InSight Health Services Holdings Corp. to Host Second Quarter Fiscal 2009 Results Conference Call

[ Thu, Feb 12th 2009 ] - Market Wire

American Shared Hospital Services to Develop Prot .. iation Therapy Facility in San Francisco Bay Area

[ Thu, Feb 12th 2009 ] - Market Wire

Shareholder Group Led by Adrenalina Announces Nom .. didates for Election to the Pacific Sunwear Board

[ Thu, Feb 12th 2009 ] - Market Wire

Curis Announces Genentech?s Initiation of Pivotal .. rial of GDC-0449 in Advanced Basal Cell Carcinoma

[ Thu, Feb 12th 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Reports Fourth Quarter and Full Year 2008 Results

[ Thu, Feb 12th 2009 ] - Market Wire

BioDelivery Sciences to Present at the ROTH Capit .. l Partners 21st Annual OC Growth Stock Conference

[ Thu, Feb 12th 2009 ] - Market Wire

Antigenics to Report Fourth Quarter and Year-End .. s on February 19, 2009; Conference Call to Follow

[ Thu, Feb 12th 2009 ] - Market Wire

Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction

[ Thu, Feb 12th 2009 ] - Market Wire

Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19

[ Thu, Feb 12th 2009 ] - Market Wire

Emergent BioSolutions anuncia que BioThrax (Vacin .. Antraz) recebe autorizao de comercializao na ndia

Wed, February 11, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

Riassunto: Emergent BioSolutions annuncia che Bio .. ed) ha ricevuto l'autorizzazione per la commercia

[ Wed, Feb 11th 2009 ] - Market Wire

Emergent BioSolutions Announces That BioThrax (An .. Adsorbed) Receives Market Authorization in India

[ Wed, Feb 11th 2009 ] - Market Wire

Theragenics® Announces Expected Goodwill Impairment Charge

[ Wed, Feb 11th 2009 ] - Market Wire

North American Scientific Signs Definitive Agreement to Divest Prostate Brachytherapy Product Line

[ Wed, Feb 11th 2009 ] - Market Wire

Oscient Pharmaceuticals Restructures Commercial Organization

[ Wed, Feb 11th 2009 ] - Market Wire

Sequenom Reports Fourth Quarter Financial Results

[ Wed, Feb 11th 2009 ] - Market Wire

Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan

[ Wed, Feb 11th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Announces Management Team Changes

[ Wed, Feb 11th 2009 ] - Market Wire

Zila Completes First Phase of Global Marketing In .. or Oral Cancer Screening Product, ViziLite® Plus

[ Wed, Feb 11th 2009 ] - Market Wire

BioScrip to Host Fourth Quarter and Year-End 2008 Earnings Call

[ Wed, Feb 11th 2009 ] - Market Wire

Bristol-Myers Squibb Statement on Mead Johnson Nutrition Company IPO

[ Wed, Feb 11th 2009 ] - Market Wire

Pacific Biometrics, Inc.: Pacific Biometrics to H .. r Conference Call on Wednesday, February 18, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

RTI Biologics Announces 2008 Fourth Quarter Earnings and Year End Earnings and Conference Call

[ Wed, Feb 11th 2009 ] - Market Wire

Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. nce of Claims Relating to Heat Shock Protein dnaJ

[ Wed, Feb 11th 2009 ] - Market Wire

BioElectronics Corporation: BioElectronics Announces Major Shipments

PDL BioPharma: PDL BioPharma to Host Fourth-Quarter and Full-Year 2008 Financial Results Conference Call on March 2, 2009

^{Published on 2009-02-20 12:42:07, Last Modified on 2009-02-20 12:42:41 - Market Wire}

INCLINE VILLAGE, NV--(Marketwire - February 20, 2009) - PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that it will release its financial results for the fourth quarter and full year 2008 following the close of the U.S. financial markets on Monday, March 2, 2009. PDL will hold a conference call to discuss these financial results and provide an update on company activities at 1:30 p.m. Pacific time, 4:30 p.m. Eastern time on March 2, 2009.

To participate in this teleconference, please dial 888-727-7622 fifteen minutes before the conference is scheduled to begin. Callers outside of the U.S. should dial 913-312-0392. The participant passcode is 2182491. The call will also be Webcast live at [ www.pdl.com ]. A replay of the call will be available for two weeks on the company's Web site, or until March 16 by dialing 888-203-1112. Callers outside of the U.S. should dial 719-457-0820. The replay passcode is 2182491.

About PDL BioPharma

PDL BioPharma, Inc. pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and autoimmune diseases. This press release and further information about PDL BioPharma, Inc. can be found at: [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Thu, Feb 19th 2009 ] - Market Wire

Santarus Reports Preliminary 2008 Total Revenues of $130 Million

[ Thu, Feb 12th 2009 ] - Market Wire

Osiris Announces Fourth Quarter and Full Year 2008 Financial Results Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of

[ Mon, Feb 02nd 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in

[ Mon, Feb 02nd 2009 ] - Market Wire

ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results

[ Thu, Jan 29th 2009 ] - Market Wire

Theravance, Inc.: Theravance to Report Fourth Qua .. Year 2008 Financial Results on February 12, 2009

[ Mon, Jan 19th 2009 ] - Market Wire

Given Imaging: Given Imaging to Host Fourth-Quart .. Full-Year 2008 Financial Results Conference Calls

[ Mon, Jan 12th 2009 ] - Market Wire

Bristol-Myers Squibb and ZymoGenetics Enter Global Collaboration on Novel Hepatitis C Compound

[ Mon, Dec 22nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA '444 in the Treatment of COPD in the Horizon D

[ Mon, Dec 15th 2008 ] - Market Wire

Aetna to Hold Conference Call with Investors

[ Tue, Dec 02nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA, '444 in the Horizon Asthma Development Progra